• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物-药物相互作用的研究方法及肾脏转运体介导的新进展。

Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters.

机构信息

Department of Pharmacy, First Affiliated Hospital of Dalian Medical University, Dalian 116011, China.

出版信息

Molecules. 2023 Jul 6;28(13):5252. doi: 10.3390/molecules28135252.

DOI:10.3390/molecules28135252
PMID:37446913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10343503/
Abstract

The kidney is critical in the human body's excretion of drugs and their metabolites. Renal transporters participate in actively secreting substances from the proximal tubular cells and reabsorbing them in the distal renal tubules. They can affect the clearance rates (CLr) of drugs and their metabolites, eventually influence the clinical efficiency and side effects of drugs, and may produce drug-drug interactions (DDIs) of clinical significance. Renal transporters and renal transporter-mediated DDIs have also been studied by many researchers. In this article, the main types of in vitro research models used for the study of renal transporter-mediated DDIs are membrane-based assays, cell-based assays, and the renal slice uptake model. In vivo research models include animal experiments, gene knockout animal models, positron emission tomography (PET) technology, and studies on human beings. In addition, in vitro-in vivo extrapolation (IVIVE), ex vivo kidney perfusion (EVKP) models, and, more recently, biomarker methods and in silico models are included. This article reviews the traditional research methods of renal transporter-mediated DDIs, updates the recent progress in the development of the methods, and then classifies and summarizes the advantages and disadvantages of each method. Through the sorting work conducted in this paper, it will be convenient for researchers at different learning stages to choose the best method for their own research based on their own subject's situation when they are going to study DDIs mediated by renal transporters.

摘要

肾脏在人体排出药物及其代谢物方面起着关键作用。肾脏转运体参与将物质从近端肾小管细胞主动分泌,并在远端肾小管中重吸收。它们可以影响药物及其代谢物的清除率(CLr),最终影响药物的临床疗效和副作用,并可能产生具有临床意义的药物-药物相互作用(DDIs)。许多研究人员也研究了肾脏转运体和肾脏转运体介导的 DDIs。在本文中,研究肾脏转运体介导的 DDIs 的主要体外研究模型包括基于膜的测定、基于细胞的测定和肾切片摄取模型。体内研究模型包括动物实验、基因敲除动物模型、正电子发射断层扫描(PET)技术和对人类的研究。此外,还包括体外-体内外推(IVIVE)、离体肾脏灌注(EVKP)模型,以及最近的生物标志物方法和计算模型。本文回顾了肾脏转运体介导的 DDIs 的传统研究方法,更新了方法的最新进展,然后对每种方法的优缺点进行分类和总结。通过本文的分类工作,不同学习阶段的研究人员在研究肾脏转运体介导的 DDIs 时,可以根据自己的课题情况,选择最适合自己研究的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/10343503/40204fb33123/molecules-28-05252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/10343503/bcd8e85d5089/molecules-28-05252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/10343503/40204fb33123/molecules-28-05252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/10343503/bcd8e85d5089/molecules-28-05252-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2560/10343503/40204fb33123/molecules-28-05252-g002.jpg

相似文献

1
Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters.药物-药物相互作用的研究方法及肾脏转运体介导的新进展。
Molecules. 2023 Jul 6;28(13):5252. doi: 10.3390/molecules28135252.
2
Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions.肾转运体介导的药物相互作用的评估与定量预测
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S110-21. doi: 10.1002/jcph.702.
3
The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.肾脏——人体的药物作用场所:肾脏药物处理概述及相关临床实例
Can J Clin Pharmacol. 2003 Spring;10(1):17-23.
4
Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs.基于正电子发射断层扫描的药代动力学分析评估抗菌药物的肾转运体介导的药物相互作用。
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0149322. doi: 10.1128/aac.01493-22. Epub 2023 Feb 14.
5
Renal drug-drug interactions: what we have learned and where we are going.肾脏药物相互作用:我们所学到的和我们的前进方向。
Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):433-48. doi: 10.1517/17425255.2012.667401. Epub 2012 Feb 29.
6
In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.在药物发现中,采用体内外方法来表征转运体介导的药物处置。
Expert Opin Drug Discov. 2014 Aug;9(8):873-90. doi: 10.1517/17460441.2014.922540. Epub 2014 May 24.
7
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.使用正电子发射断层显像(PET)成像评估转运体介导的药物相互作用。
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S143-56. doi: 10.1002/jcph.722.
8
Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug-Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective.利用药物开发中的内源性生物标志物简化药物 - 药物相互作用的评估:制药行业的视角。
Clin Pharmacokinet. 2024 Jun;63(6):735-749. doi: 10.1007/s40262-024-01385-0. Epub 2024 Jun 13.
9
Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.应用正电子发射断层扫描研究组织中转运体介导的药物相互作用。
Clin Pharmacol Ther. 2014 Aug;96(2):206-13. doi: 10.1038/clpt.2014.70. Epub 2014 Mar 28.
10
Quantitative prediction of renal transporter-mediated clinical drug-drug interactions.肾转运体介导的临床药物相互作用的定量预测
Mol Pharm. 2013 Nov 4;10(11):4207-15. doi: 10.1021/mp400295c. Epub 2013 Oct 10.

引用本文的文献

1
Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.超越钠-葡萄糖协同转运蛋白2:近端肾小管转运体作为慢性肾脏病的潜在药物靶点
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i18-i28. doi: 10.1093/ndt/gfae211.

本文引用的文献

1
OAT3 Participates in Drug-Drug Interaction between Bentysrepinine and Entecavir through Interactions with M8-A Metabolite of Bentysrepinine-In Rats and Humans In Vitro.OAT3 通过与 Bentysrepinine 的 M8-A 代谢物在大鼠和人体中的相互作用参与 Bentysrepinine 和恩替卡韦的药物相互作用。
Molecules. 2023 Feb 20;28(4):1995. doi: 10.3390/molecules28041995.
2
Positron Emission Tomography-Based Pharmacokinetic Analysis To Assess Renal Transporter-Mediated Drug-Drug Interactions of Antimicrobial Drugs.基于正电子发射断层扫描的药代动力学分析评估抗菌药物的肾转运体介导的药物相互作用。
Antimicrob Agents Chemother. 2023 Mar 16;67(3):e0149322. doi: 10.1128/aac.01493-22. Epub 2023 Feb 14.
3
Kidney Drug Transporters in Pharmacotherapy.
药物治疗中的肾脏药物转运体。
Int J Mol Sci. 2023 Feb 2;24(3):2856. doi: 10.3390/ijms24032856.
4
Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research.三维(3D)体外细胞培养方案以增强脑胶质瘤研究。
PLoS One. 2023 Feb 8;18(2):e0276248. doi: 10.1371/journal.pone.0276248. eCollection 2023.
5
Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing.肝细胞转运体在药物性肝损伤(DILI)体外检测中的作用
Pharmaceutics. 2022 Dec 22;15(1):29. doi: 10.3390/pharmaceutics15010029.
6
Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs.市售药物中乳腺癌耐药蛋白(BCRP,ABCG2)的新型抑制剂。
Eur J Pharm Sci. 2023 Feb 1;181:106362. doi: 10.1016/j.ejps.2022.106362. Epub 2022 Dec 15.
7
Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.利用 POT 和 LAT 载体运输生物活性超短肽。
Int J Mol Sci. 2022 Jul 13;23(14):7733. doi: 10.3390/ijms23147733.
8
Challenges and Opportunities for Improved Drug-Drug Interaction Predictions for Renal OCT2 and MATE1/2-K Transporters.改善肾脏OCT2和MATE1/2-K转运体药物相互作用预测的挑战与机遇
Clin Pharmacol Ther. 2022 Sep;112(3):562-572. doi: 10.1002/cpt.2666. Epub 2022 Jun 25.
9
Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P-glycoprotein induction and inhibition in the intestine, liver, and kidney.稳健的基于生理学的利福平药代动力学模型,用于预测通过肠、肝和肾中的 P-糖蛋白诱导和抑制产生的药物-药物相互作用。
CPT Pharmacometrics Syst Pharmacol. 2022 Jul;11(7):919-933. doi: 10.1002/psp4.12807. Epub 2022 Jun 6.
10
Magnitude of Drug-Drug Interactions in Special Populations.特殊人群中药物相互作用的程度。
Pharmaceutics. 2022 Apr 4;14(4):789. doi: 10.3390/pharmaceutics14040789.